Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Garner

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 6, 2003
Early microdose drug studies in human volunteers can minimise animal testing: Proceedings of a workshop organised by Volunteers in Research and TestingR D Combes, T Berridge, J Connelly, et al.
Carcinogenesis|April 1, 1985
Evidence for N-(deoxyguanosin-8-yl)-1-aminopyrene as a major DNA adduct in female rats treated with 1-nitropyreneC A Stanton, F L Chow, D H Phillips, et al.
IARC Scientific Publications|January 1, 1990
Linear relationship between DNA adducts in human lung and cigarette smokingR C Garner, J Cuzick, D Jenkins, et al.
Environmental Mutagenesis|January 1, 1986
Bacterial mutagenicity and chemical analysis of polycyclic aromatic hydrocarbons and some nitro derivatives in environmental samples collected in West GermanyR C Garner, C A Stanton, C N Martin, et al.
Molecular Carcinogenesis|October 1, 1994
Activation of promutagens in a human bronchial epithelial cell line stably expressing human cytochrome P450 1A2K Macé, F J Gonzalez, I R McConnell, et al.
Mutagenesis|January 1, 1990
The mutagenic activity of ethylmethanesulphonate, benzidine and benzo[a]pyrene at the hprt locus of wild-type L5178Y mouse lymphoma cellsJ C Kennelly, C B Clare, J Campbell, et al.
Journal of Clinical Pharmacology|March 24, 2006
Determination of the bioavailability of [14C]-hexaminolevulinate using accelerator mass spectrometry after intravesical administration to human volunteersB Klem, G Lappin, S Nicholson, et al.
Mutation Research|May 12, 1997
MeIQx-DNA adduct formation in rodent and human tissues at low dosesK W Turteltaub, R J Mauthe, K H Dingley, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 29, 2000
A validation study comparing accelerator MS and liquid scintillation counting for analysis of 14C-labelled drugs in plasma, urine and faecal extractsR C Garner, J Barker, C Flavell, et al.
IARC Scientific Publications|January 1, 1984
An enzyme-linked immunosorbent procedure for assaying aflatoxin B1C N Martin, R C Garner, F Tursi, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 6, 2003
Early microdose drug studies in human volunteers can minimise animal testing: Proceedings of a workshop organised by Volunteers in Research and TestingR D Combes, T Berridge, J Connelly, et al.
Carcinogenesis|April 1, 1985
Evidence for N-(deoxyguanosin-8-yl)-1-aminopyrene as a major DNA adduct in female rats treated with 1-nitropyreneC A Stanton, F L Chow, D H Phillips, et al.
IARC Scientific Publications|January 1, 1990
Linear relationship between DNA adducts in human lung and cigarette smokingR C Garner, J Cuzick, D Jenkins, et al.
Environmental Mutagenesis|January 1, 1986
Bacterial mutagenicity and chemical analysis of polycyclic aromatic hydrocarbons and some nitro derivatives in environmental samples collected in West GermanyR C Garner, C A Stanton, C N Martin, et al.
Molecular Carcinogenesis|October 1, 1994
Activation of promutagens in a human bronchial epithelial cell line stably expressing human cytochrome P450 1A2K Macé, F J Gonzalez, I R McConnell, et al.
Mutagenesis|January 1, 1990
The mutagenic activity of ethylmethanesulphonate, benzidine and benzo[a]pyrene at the hprt locus of wild-type L5178Y mouse lymphoma cellsJ C Kennelly, C B Clare, J Campbell, et al.
Journal of Clinical Pharmacology|March 24, 2006
Determination of the bioavailability of [14C]-hexaminolevulinate using accelerator mass spectrometry after intravesical administration to human volunteersB Klem, G Lappin, S Nicholson, et al.
Mutation Research|May 12, 1997
MeIQx-DNA adduct formation in rodent and human tissues at low dosesK W Turteltaub, R J Mauthe, K H Dingley, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 29, 2000
A validation study comparing accelerator MS and liquid scintillation counting for analysis of 14C-labelled drugs in plasma, urine and faecal extractsR C Garner, J Barker, C Flavell, et al.
IARC Scientific Publications|January 1, 1984
An enzyme-linked immunosorbent procedure for assaying aflatoxin B1C N Martin, R C Garner, F Tursi, et al.
Pageof 10